Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing proguanil hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
chlorhydrate de proguanil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Proguanil hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
chlorhydrate de proguanil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atovaquone+proguanil hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
chlorhydrate de proguanil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atovaquone+proguanil hydrochloride 250mg/100mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
chlorhydrate de proguanil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Proguanil hydrochloride+chloroquine phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
chlorhydrate de proguanil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Proguanil hydrochloride tablet+chloroquine phosphate tablet 100mg/250mg pack (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
chlorhydrate de proguanil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
chlorhydrate de proguanil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Proguanil hydrochloride tablet+chloroquine phosphate tablet 100mg/250mg pack (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
chlorhydrate de proguanil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Proguanil hydrochloride+chloroquine phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
chlorhydrate de proguanil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Proguanil hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
chlorhydrate de proguanil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Proguanil hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
chlorhydrate de proguanil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Proguanil hydrochloride 100 mg oral tablet |
Has basis of strength substance (attribute) |
True |
chlorhydrate de proguanil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Proguanil hydrochloride 100 mg oral tablet |
Has precise active ingredient |
True |
chlorhydrate de proguanil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atovaquone 62.5 milligram and proguanil hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
chlorhydrate de proguanil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely atovaquone 62.5 milligram and proguanil hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
chlorhydrate de proguanil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely atovaquone 250 milligram and proguanil hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
chlorhydrate de proguanil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely atovaquone 250 milligram and proguanil hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
chlorhydrate de proguanil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |